3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide has been researched along with Brain Damage, Chronic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cryssagis, K; Pogarell, O; Reichart, B; Schwarz, J; Tatsch, K; Welz, A | 1 |
1 other study(ies) available for 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Brain Damage, Chronic
| Article | Year |
|---|---|
Surgery of the thoracic aorta using deep hypothermic total circulatory arrest. Are there neurological consequences other than frank cerebral defects?
Topics: Adult; Aged; Aortic Aneurysm, Thoracic; Aortic Dissection; Benzamides; Brain Damage, Chronic; Corpus Striatum; Dopamine Antagonists; Female; Follow-Up Studies; Heart Arrest, Induced; Humans; Iodine Radioisotopes; Male; Middle Aged; Neuropsychological Tests; Postoperative Complications; Psychometrics; Pyrrolidines; Receptors, Dopamine D2; Reference Values; Retrospective Studies; Tomography, Emission-Computed, Single-Photon | 1997 |